4//SEC Filing
Craig Adam R 4
Accession 0001628280-25-040441
CIK 0001501697other
Filed
Aug 13, 8:00 PM ET
Accepted
Aug 14, 8:31 PM ET
Size
9.4 KB
Accession
0001628280-25-040441
Insider Transaction Report
Form 4
Craig Adam R
DirectorExecutive Chairman
Transactions
- Award
Common Stock
2025-08-14+289,881→ 289,881 total - Award
Stock Option (right to buy)
2025-08-12+1,609,873→ 1,609,873 totalExercise: $1.42Exp: 2035-08-12→ Common Stock (1,609,873 underlying) - Award
Stock Option (right to buy)
2025-08-14+529,201→ 529,201 totalExercise: $3.14Exp: 2035-08-14→ Common Stock (529,201 underlying)
Footnotes (2)
- [F1]Represents restricted stock units (RSUs) granted to the Reporting Person. One third of the RSUs shall vest on each of August 12, 2026, August 12, 2027 and August 12, 2028, subject to the Reporting Person continuing to provide services through each such date and contingent upon approval of the grant at the Issuer's 2026 Annual Meeting of Stockholders.
- [F2]One third of the shares subject to the option shall vest on August 12, 2026, with the remainder vesting in equal installments each successive month thereafter for a period of 24 months, subject to the Reporting Person continuing to provide services through each such date.
Documents
Issuer
X4 Pharmaceuticals, Inc
CIK 0001501697
Entity typeother
Related Parties
1- filerCIK 0001339498
Filing Metadata
- Form type
- 4
- Filed
- Aug 13, 8:00 PM ET
- Accepted
- Aug 14, 8:31 PM ET
- Size
- 9.4 KB